Sep 22, 2016, 12:09 PM by Michael Croft

STAT | Agriculture giant Monsanto has licensed CRISPR-Cas9 genome-editing technology from the Broad Institute to develop modified seeds.

Sep 22, 2016, 08:22 AM by Michael Croft

HLOHOVEC, SLOVAKIA - Sep 22, 2016 - Slovakia-based contract development and manufacturing organisation (CDMO) Saneca Pharma has added senior talent to its team to position the company for its next phase of growth

Sep 21, 2016, 13:55 PM by Michael Croft

TOP500 | The path to exascale computing hasn't been an easy one. It has had to face a daunting set of challenges in energy efficiency, application parallelism, and system reliability, just to name a few. The difficulties in bringing the hardware and software up to this level is considerable, but there is a more fundamental challenge at the heart of exascale: doing the necessary work of building an ecosystem that will last for a decade or more, not just for a handful stunt machines.

Sep 21, 2016, 10:00 AM by Michael Croft

Bio-IT World | As far as their employees are concerned, who among these life-science players are putting their money where their mouths are? The search has been on at Bio-IT World for those organizations who are taking the logical step of subsidizing the sequencing their own employees' genomes and the clinical interpretation thereof.

Sep 20, 2016, 14:56 PM by Michael Croft

EAST SUITE, UT, UNITED STATES - Sep 21, 2016 - Stem cells are found inside different types of tissues in the human body. As the name suggests, these cells generate from a single stem cell

Sep 20, 2016, 10:14 AM by Michael Croft

Forbes | Yesterday, the Food and Drug Administration made history, approving a drug to treat Duchenne muscular dystrophy that works by targeting the genetic mutation at the root of the disease. The decision was unique for reasons that were not just scientific.

Sep 19, 2016, 15:15 PM by Michael Croft

Bio-IT World News Brief | St. Jude's Children's Research Hospital's agreement with the Wellcome Trust Sanger Institute unifies the institute's COSMIC database with the data mining and visualization system of the hospital to better understand the nature of childhood cancers.

Sep 19, 2016, 10:15 AM by Michael Croft

Bio-IT World | The second annual Converged IT Summit covers an impressive list of speakers expanding the realms of infrastructure and data science. The speakers cover a variety of subjects, such as personalized cardiac therapy, IT for life sciences, and much more.

Sep 19, 2016, 09:53 AM by Michael Croft

Computerworld | Larry Ellison has a message for Amazon Web Services: Oracle will give Amazon a run for its money in the cloud market.

Sep 16, 2016, 15:52 PM by Michael Croft

Nature News & Comment | Alleged theft from Italian gene bank dismissed - but ownership of samples remains under investigation.

Sep 16, 2016, 13:28 PM by Michael Croft

STAT | The judges hearing a patent dispute over the discovery of CRISPR genome-editing technology denied a request to subpoena Harvard biologist George Church.

Sep 16, 2016, 10:33 AM by Michael Croft

BERLIN, GERMANY - Sep 16, 2016 - International Contract Research Organization (CRO) KCR announces its Patient Recruitment & Retention Days, which will be taking place from 15 September to 15 December 2016

Sep 16, 2016, 07:30 AM by Michael Croft

Bio-IT World | Researchers at A*STAR, Singapore, and China National Genebank have successfully sequenced the genome of the ocean sunfish. This is a key step in answering questions about what goes into making this mysterious fish so unique.

Sep 15, 2016, 08:00 AM by Michael Croft

Bio-IT World News | Broad Institute’s Bill Mayo is setting lofty goals for the future of the research institute. He’s got big plans for connecting to the Broadies off-sight, machine learning in clinical trials, and upgrading on-sight storage. He’s thoroughly enjoying all of it.

Sep 14, 2016, 10:22 AM by Michael Croft

Xconomy | A group of scientists and entrepreneurs believe that computers and various biotechnologies can determine how proteins, instead of folding into a permanent shape, shimmy from one shape to another, and how those back-and-forth states can be exploited to treat disease. They've formed a startup called Relay Therapeutics to test the concept and make drugs for cancer and other diseases.

Sep 13, 2016, 10:23 AM by Michael Croft

STAT | Moderna's caustic work environment has driven away top talent. There are signs the secretive startup has hit roadblocks with its most ambitious projects.

Sep 13, 2016, 09:36 AM by Michael Croft

The New York Times | This year's honors speak to the additive nature of scientific research, with prizes recognizing people who built on the findings of others.

Sep 12, 2016, 14:20 PM by Michael Croft

Bio-IT World News Science reporter Ledford discusses advisory panel's list of recommendations in congruence with the US Cancer Moonshot Initiative.

Sep 12, 2016, 10:13 AM by Michael Croft

Boston Business Journal | The question remains whether CRISPR can do much better on the stock market than the other two publicly-traded gene editing companies, both of which are based in Cambridge and held IPOs earlier this year.

Sep 12, 2016, 05:03 AM by Michael Croft

SPAIN, SPAIN - Sep 12, 2016 - A Spanish contract development and manufacturing organisation (CDMO) has secured investment from Madrid-headquartered Suanfarma S